FAM123B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.072600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.176400E-01
Normal-vs-Stage2
9.648100E-02
Normal-vs-Stage3
6.218500E-02
Normal-vs-Stage4
7.545000E-01
Stage1-vs-Stage2
7.576000E-01
Stage1-vs-Stage3
7.295900E-02
Stage1-vs-Stage4
3.594600E-01
Stage2-vs-Stage3
2.075200E-01
Stage2-vs-Stage4
3.199800E-01
Stage3-vs-Stage4
1.543420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.058980E-01
Normal-vs-AfricanAmerican
2.928800E-01
Normal-vs-Asian
1.115220E-01
Caucasian-vs-AfricanAmerican
6.202000E-01
Caucasian-vs-Asian
6.163600E-01
AfricanAmerican-vs-Asian
4.681000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.095220E-01
Normal-vs-Female
1.196430E-01
Male-vs-Female
5.203000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.588400E-01
Normal-vs-Age(41-60Yrs)
1.601350E-01
Normal-vs-Age(61-80Yrs)
1.090200E-01
Normal-vs-Age(81-100Yrs)
8.596100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.502400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.816800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.572600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.479200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.656200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.950200E-02
Normal-vs-Daily Drinker
5.225800E-02
Normal-vs-Weekly Drinker
2.236400E-01
Normal-vs-Occasional Drinker
1.833760E-01
Normal-vs-Social Drinker
2.630200E-01
Non Drinker-vs-Daily Drinker
5.509800E-01
Non Drinker-vs-Weekly Drinker
2.186800E-01
Non Drinker-vs-Occasional Drinker
8.249200E-01
Non Drinker-vs-Social Drinker
5.861500E-02
Daily Drinker-vs-Weekly Drinker
1.518000E-01
Daily Drinker-vs-Occasional Drinker
5.313800E-01
Daily Drinker-vs-Social Drinker
4.708000E-02
Weekly Drinker-vs-Occasional Drinker
5.039600E-01
Weekly Drinker-vs-Social Drinker
6.483400E-01
Occasional Drinker-vs-Social Drinker
2.673000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.198400E-01
Normal-vs-Grade 2
6.299600E-02
Normal-vs-Grade 3
5.753500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.839600E-02
Grade 1-vs-Grade 3
4.926400E-02
Grade 1-vs-Grade 4
2.198400E-01
Grade 2-vs-Grade 3
5.470400E-01
Grade 2-vs-Grade 4
6.299600E-02
Grade 3-vs-Grade 4
5.753500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.368300E-02
Normal-vs-NonDiabetic
4.669900E-02
Diabetic-vs-NonDiabetic
9.770800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.170100E-02
Normal-vs-NoPancreatitis
6.183700E-02
Pancreatitis-vs-NoPancreatitis
5.150200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.400100E-02
Normal-vs-N1
1.350800E-01
N0-vs-N1
2.471800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.703200E-01
Normal-vs-TP53-NonMutant
2.513400E-01
TP53-Mutant-vs-TP53-NonMutant
7.686000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
